New Diabetes Drug Expected by 2011

Filed in archive News on September 29, 2006

An Indian company hopes to market their own diabetes drug within 5 years and give the competition something to worry about.

India's third-largest drugmaker began researching new drugs in 1993. The first candidate to emerge from its own labs will enter the final stage of human testing next year and may be available by 2011, said Chairman K. Anji Reddy.

In the last decade, it created balaglitazone to sensitize the body's ability to use insulin. The molecule is a so-called glitazone, a new class of treatment for sufferers of type 2 diabetes.

Did you know diabetes drugs are the fastest-growing products in the pharmaceutical market? Talk about your double-edged sword.

(Photo Source: BAHM)